Subscribe

What are you looking for?

Main Menu

明報新聞網

信達與美藥廠禮來合作 全球研發腫瘤及免疫創新藥

Future Wealths
Future Wealths
8 2 月, 2026
One Min Read
7 Views
0 Comments
信達生物（1801）公布，與美國藥廠禮來達成戰略合作，攜手推進腫瘤及免疫領域創新藥物的全球研發。今次協議為雙方第七次合作，進一步深化了雙方長期且富有成效的合作夥伴關係，攜手為全球患者帶來創新藥物。這一獨特的合作架構也為公司打造了全新的合作模式，加速公司創新研發管線的全球化開發進程。

原文: https://finance.mingpao.com/fin/instantf/20260208/1770546256240/%E4%BF%A1%E9%81%94%E8%88%87%E7%BE%8E%E8%97%A5%E5%BB%A0%E7%A6%AE%E4%BE%86%E5%90%88%E4%BD%9C-%E5%85%A8%E7%90%83%E7%A0%94%E7%99%BC%E8%85%AB%E7%98%A4%E5%8F%8A%E5%85%8D%E7%96%AB%E5%89%B5%E6%96%B0%E8%97%A5%22%20target=%22blank

Last Update: 8 2 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept